Read-Gene S.A. (WSE: RDG)
Poland flag Poland · Delayed Price · Currency is PLN
4.960
0.00 (0.00%)
Jan 20, 2025, 10:45 AM CET

Read-Gene Revenue

Read-Gene had revenue of 3.34M PLN in the quarter ending September 30, 2024, with 45.40% growth. This brings the company's revenue in the last twelve months to 12.67M, up 48.35% year-over-year. In the year 2023, Read-Gene had annual revenue of 10.15M with 40.14% growth.

Revenue (ttm)
12.67M
Revenue Growth
+48.35%
P/S Ratio
4.28
Revenue / Employee
575.93K
Employees
29
Market Cap
54.23M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202310.15M2.91M40.14%
Dec 31, 20227.24M787.35K12.20%
Dec 31, 20216.45M384.57K6.34%
Dec 31, 20206.07M-296.62K-4.66%
Dec 31, 20196.37M-758.81K-10.65%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
NEUCA 12.34B
Synektik Spólka Akcyjna 624.80M
Voxel 492.41M
Celon Pharma 209.54M
Selvita 334.42M
Ryvu Therapeutics 91.18M
Centrum Medyczne ENEL-MED 680.32M
Mercator Medical 488.78M
Revenue Rankings